SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-026883
Filing Date
2022-10-24
Accepted
2022-10-24 16:16:44
Documents
4
Period of Report
2022-10-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 126481
2 image1a.jpg GRAPHIC 292870
3 image_0a.jpg GRAPHIC 7178
4 imagea.jpg GRAPHIC 640299
  Complete submission text file 0001628280-22-026883.txt   1423174
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36783 | Film No.: 221326225
SIC: 2834 Pharmaceutical Preparations